INIS
patients
100%
ischemia
93%
brain
76%
rats
69%
edema
66%
injuries
57%
receptors
54%
hemorrhage
38%
nitric oxide
36%
volume
33%
in vivo
32%
cerebral arteries
31%
therapy
30%
infusion
30%
data
30%
blood flow
27%
reviews
25%
comparative evaluations
24%
mice
22%
production
21%
administration
21%
management
20%
water content
20%
piperidines
19%
surgery
19%
diseases
18%
pools
18%
levels
18%
control
17%
arginine
16%
males
16%
dopamine
15%
ligands
14%
risks
14%
drugs
13%
appraisal
13%
animals
12%
acetates
11%
water
11%
hospitals
11%
units
11%
carbon 14
10%
blood-brain barrier
10%
velocity
10%
recovery
10%
mortality
10%
hypothermia
9%
vasopressin
9%
vehicles
9%
hypothesis
9%
Neuroscience
Ischemia
41%
Cerebral Edema
35%
Stroke
28%
Brain
27%
Middle Cerebral Artery
26%
Neuroprotection
20%
Receptor Agonists
19%
Nitric Oxide
19%
Neuroprotective Agent
18%
Brain Injury
17%
Aquaporin 4
15%
Striatum
14%
In Vivo
13%
Ischemic Stroke
11%
Subarachnoid Hemorrhage
10%
Halothane
10%
Dopamine
10%
Infarction
9%
Piperidine
9%
δ -Opioid Receptor
9%
Mannitol
9%
Aspartic Acid
8%
Acetate
8%
Hypothermia
8%
Chloride
7%
Miconazole
6%
Aneurysm
6%
Hippocampus
6%
Nitric Oxide Synthase
6%
Nitrous Oxide
6%
Eicosanoid Receptor
5%
Microdialysis
5%
Epoxyeicosatrienoic Acid
5%
Glucose
5%
Transcranial Doppler
5%
Keyphrases
Neuroprotection
10%
Piperidine
9%
Phenyl
9%
Dopamine
9%
Ligand-receptor Binding
7%
A1 Receptor
7%
Cerebral Edema
7%
Experimental Stroke
6%
Aquaporin-4 (AQP4)
6%
Neuronal Nitric Oxide
6%
Hypertonic Saline
6%
Ischemia
5%
Transient Focal Ischemia
5%
Transient Middle Cerebral Artery Occlusion (tMCAO)
5%